person

Ulrich M. L.

Country
Germany
Department
Medizinische Klinik-Innere Medizin VIII, Universitätsklinikum Tübingen

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
2
Sites with multiple studies

Has run more than one trial at 2 of 23 partner sites.

Specializations

Hematologic Malignancies

The investigator leads studies on a spectrum of blood‑cancer entities, emphasizing therapeutic strategies for acute and chronic leukemias and related myeloid disorders.

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Chronic Lymphocytic Leukemia
  • Myelodysplastic Syndromes
  • Multiple Myeloma

All investigations are conducted at the Universitätsklinikum Tübingen AöR, integrating advanced hematologic expertise.

Solid Tumor Oncology

Focused on malignant solid neoplasms, the work spans gastrointestinal, thoracic, urologic and gynecologic cancers, with a particular interest in targeted and immunotherapeutic approaches.

  • Non‑Small Cell Lung Cancer
  • Colorectal Cancer
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma
  • Metastatic Breast Cancer

The clinical portfolio reflects a commitment to advancing care for patients with advanced and refractory solid tumors.

Cardiovascular & Metabolic Diseases

Research activities address acute coronary events, heart failure phenotypes, and metabolic complications of chronic kidney disease.

  • Acute Coronary Syndrome
  • Heart Failure with Preserved Ejection Fraction
  • Atrial Fibrillation
  • Anemia associated with Chronic Kidney Disease
  • Prediabetes

These studies aim to refine therapeutic options for cardiovascular risk reduction and metabolic regulation.

Autoimmune & Inflammatory Disorders

Investigations encompass systemic autoimmune diseases and organ‑specific inflammatory conditions, targeting disease activity modulation.

  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Inflammatory Bowel Disease
  • Atopic Dermatitis

Therapeutic focus includes biologic and small‑molecule agents to control immune‑mediated pathology.

Neurological & Ophthalmic Conditions

The clinical portfolio includes neurodegenerative diseases, stroke, and inherited retinal disorders, emphasizing disease‑modifying interventions.

  • Acute Ischemic Stroke
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Age‑Related Macular Degeneration
  • Retinitis Pigmentosa

These efforts support the development of innovative therapies for complex neurologic and visual disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.